FDA Drug recall D-600-2013
MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count capsules in Green & Blue Boxes, Formulated and distribute…
- FDA Drug
- Class I
- terminated
- Published 2013-06-19
On 2013-06-19 the FDA classified a Class I recall of MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count capsules in Green & Blue Boxes, Formulated and distribute… by Olaax International, citing marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved n….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-600-2013 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2013-02-12 |
| Published | 2013-06-19 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Olaax International |
| Distribution | US |
Product
MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count capsules in Green & Blue Boxes, Formulated and distributed by Olaax Corp, Lakeland, FL
Reason
Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.
Identifiers
| code_info | All Lots |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-600-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.